The familial periodic paralyses and nondystrophic myotonias

American Journal of Medicine

Volumn 105, Issue 1, 1998, Pages 58-70

  Ptáček, Louis ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; SODIUM CHANNEL;

FAMILIAL DISEASE; GENE MUTATION; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MYOTONIA; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THOMSEN DISEASE;

EID: 0032126806     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00123-5     Document Type: Article

References (79)

1. Ptáček L.J., Johnson K.J., Griggs R.C. Genetics and physiology of the myotonic muscle disorders. NEJM. 328:1993;482-489.
2. Ptáček L.J., George A.L. Jr, Griggs R.C., et al. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell. 67:1991;1021-1027.
3. Rojas C.V., Wang J.Z., Schwartz L.S., et al. A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature. 354:1991;387-389.
4. Ptáček L.J., George A.L. Jr, Barchi R.L., et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron. 8:1992;891-897.
5. McClatchey A.I., Van den Bergh P., Pericak Vance M.A., et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell. 68:1992;769-774.
6. Ptáček L.J., Tawil R., Griggs R.C., et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology. 44:1994;1500-1503.
7. Heine R., Pika U., Lehmann Horn F. A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet. 2:1993;1349-1353.
8. Griggs R.C., Ptáček L.J. The periodic paralyses. Hosp Pract Off Ed. 27:1992;123-137.
9. Ptáček LJ. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromusc Disord 1997. 1997;7:250-255.
10. Ptáček L.J. Channelopathies ion channels and paroxysmal disorders of the nervous system . Genton P. Genetics of Focal Epilepsies. 1997;John Libbey, London.
11. Tyler F.H., Stephens F.E., Gunn F.D., Perkoff G.T. Studies in disorders of muscle VII. Clinical manifestations and inheritance of a type of periodic paralysis without hypopotassimia. J Clin Invest. 30:1951;492-502.
12. Eulenburg A. Über eine familiäre, durch 6 Generationen verfolgbare Form Congenitaler Paramyonie. Zentralbl Neurol. 5:1886;265-272.
13. Jackson C.E., Barohn R.J., Ptáček L.J. Paramyotonia congenita abnormal short exercise test, and improvement after mexiletine therapy . Muscle Nerve. 17:1994;763-768.
14. Trudell R.G., Kaiser K.K., Griggs R.C. Acetazolamide-responsive myotonia congenita. Neurology. 37:1987;488-491.
15. Westphal C. über einen merkqurdigen fall von periodischer lahmung aller vier extremitaten mit gleichzeitigem erloschen der elektrischen erregbarkeit wahrend der lahmung. Klin Wochenschr. 22:1885;489-491.
16. Biemond A., Daniels A.P. Familial periodic paralysis and its transition into spinal muscular atrophy. Brain. 57:1934;90-108.
17. Ptáček L.J., Griggs R.C. Familial periodic paralyses. Andreoli T. The Molecular Biology of Membrane Transport Disorders. 3rd ed. 1996;Plenum, New York.
18. Torres C.F., Griggs R.C., Moxley R.T., Bender A.N. Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology. 31:1981;1423-1428.
19. Fouad G., Dalakas M., Servedei S., et al. Genotype-phenotype correlations of DHP receptor alpha-1 gene mutations causing hypokalemic periodic paralysis. Neuromusc Disord. 7:1997;33-38.
20. Elbaz A., Vale Santos J., Jurkat Rott K., et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3) genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families . Am J Hum Genet. 56:1995;374-380.
21. Andersen E.D., Krasilnikoff P.A., Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. Acta Paediatr Scand. 60:1971;559-564.
22. Tawil R., Ptáček L.J., Pavlakis S.G., et al. Andersen's syndrome potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features . Ann Neurol. 35:1994;326-330.
23. Gancher S.T., Nutt J.G. Autosomal dominant episodic ataxia a heterogeneous syndrome . Mov Disord. 1:1986;239-253.
24. Browne D.L., Gancher S.T., Nutt J.G., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 8:1994;136-140.
25. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ gene CACNL1A4. Cell. 87:1996;543-552.
26. Griggs R.C., Moxley R.T., Lafrance R.A., McQuillen J. Hereditary paroxysmal ataxia response to acetazolamide . Neurology. 28:1978;1259-1264.
27. Ptáček L.J., Tyler F., Trimmer J.S., et al. Analysis in a large hyperkalemic periodic paralysis pedigree supports tight linkage to a sodium channel locus. Am J Hum Genet. 49:1991;378-382.
28. Vassilev P.M., Scheuer T., Catterall W.A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science. 241:1988;1658-1661.
29. Stuhmer W., Conti F., Suzuki H., et al. Structural parts involved in activation and inactivation of the sodium channel. Nature. 339:1989;597-603.
30. Moorman J.R., Kirsch G.E., Brown A.M., Joho R.H. Changes in sodium channel gating produced by point mutations in a cytoplasmic linker. Science. 250:1990;688-691.
31. Tanabe T., Beam K.G., Adams B.A., et al. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature. 346:1990;567-569.
32. Tanabe T., Beam K.G., Powell J.A., Numa S. Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature. 336:1988;134-139.
33. Perez Reyes E., Kim H.S., Lacerda A.E., et al. Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle. Nature. 340:1989;233-236.
34. Knudson C.M., Chaudhari N., Sharp A.H., et al. Specific absence of the alpha 1 subunit of the dihydropyridine receptor in mice with muscular dysgenesis. J Biol Chem. 264:1989;1345-1348.
35. Beam K.G., Knudson C.M., Powell J.A. A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells. Nature. 320:1986;168-170.
36. Chaudhari N. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. J Biol Chem. 267:1992;25636-25639.
37. Ptáček L.J., Tawil R., Griggs R.C., et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell. 77:1994;863-868.
38. Hoshi T., Zagotta W.N., Aldrich R.W. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science. 250:1990;533-538.
39. Steinmeyer K., Klocke R., Ortland C., et al. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature. 354:1991;304-308.
40. Jentsch T.J., Steinmeyer K., Schwarz G. Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature. 348:1990;510-514.
41. Thiemann A., Grunder S., Pusch M., Jentsch T.J. A chloride channel widely expressed in epithelial and non-epithelial cells. Nature. 356:1992;57-60.
42. Hanke W., Miller C. Single chloride channels from Torpedo electroplax. Activation by protons. J Gen Physiol. 82:1983;25-45.
43. Bauer C.K., Steinmeyer K., Schwarz J.R., Jentsch T.J. Completely functional double-barreled chloride channel expressed from a single Torpedo cDNA. Proc Natl Acad Sci USA. 88:1991;11052-11056.
44. Lehmann Horn F., Kuther G., Ricker K., et al. Adynamia episodica hereditaria with myotonia a non-inactivating sodium current and the effect of extracellular pH . Muscle Nerve. 10:1987;363-374.
45. Fontaine B., Khurana T.S., Hoffman E.P., et al. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science. 250:1990;1000-1002.
46. Ebers G.C., George A.L., Barchi R.L., et al. Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene. Ann Neurol. 30:1991;810-816.
47. Lehmann Horn F., Rudel R., Ricker K. Membrane defects in paramyotonia congenita (Eulenburg). Muscle Nerve. 10:1987;633-641.
48. Ptáček L.J., Trimmer J.S., Agnew W.S., et al. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am J Hum Genet. 49:1991;851-854.
49. Ptáček L.J., Tawil R., Griggs R.C., et al. Linkage of atypical myotonia congenita to a sodium channel locus. Neurology. 42:1992;431-433.
50. Ptáček L.J., Gouw L., Kwiecinski H., et al. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol. 33:1993;300-307.
51. Rudolph J.A., Spier S.J., Byrns G., et al. Periodic paralysis in quarter horses a sodium channel mutation disseminated by selective breeding . Nat Genet. 2:1992;144-147.
52. Wang J., Dubowitz V., Lehmann Horn F., et al. In vivo sodium channel structure/function studies consecutive Arg1448 changes to Cys, His, and Pro at the extracellular surface of IVS4 . Soc Gen Physiol Ser. 50:1995;77-88.
53. de Silva S.M., Kuncl R.W., Griffin J.W., et al. Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family. Muscle Nerve. 13:1990;21-26.
54. McClatchey A.I., McKenna Yasek D., Cros D., et al. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet. 2:1992;148-152.
55. Lerche H., Heine R., Pika U., et al. Human sodium channel myotonia slowed channel inactivation due to substitutions for a glycine within the III-IV linker . J Physiol Lond. 470:1993;13-22.
56. Cummins T.R., Zhou J., Sigworth F.J., et al. Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis. Neuron. 10:1993;667-678.
57. Cannon S.C., Strittmatter S.M. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron. 10:1993;317-326.
58. Yang N., Ji S., Zhou M., et al. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc Natl Acad Sci USA. 91:1994;12785-12789.
59. Mitrovic N., George A.L. Jr, Heine R., et al. K(+)-aggravated myotonia destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation . J Physiol Lond. 478:(pt 3):1994;395-402.
60. Rudel R., Lehmann Horn F., Ricker K., Kuther G. Hypokalemic periodic paralysis in vitro investigation of muscle fiber membrane parameters . Muscle Nerve. 7:1984;110-120.
61. Fontaine B., Vale Santos J., Jurkat Rott K., et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet. 6:1994;267-272.
62. Jurkat Rott K., Lehmann Horn F., Elbaz A., et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet. 3:1994;1415-1419.
63. Lipicky R.J., Bryant S.H. A biophysical study of the human myotonias. Desmedt J.E. New Developments in Electromyography and Clinical Neurophysiology. 1973;451-463 Karger, Basel.
64. Abdalla J.A., Casley W.L., Cousin H.K., et al. Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet. 51:1992;579-584.
65. Mehrke G., Brinkmeier H., Jockusch H. The myotonic mouse mutant ADR electrophysiology of the muscle fiber . Muscle Nerve. 11:1988;440-446.
66. Koch M.C., Steinmeyer K., Lorenz C., et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science. 257:1992;797-800.
67. Zhang J., George A.L., Griggs R.C., Ptáček L.J., et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology. 47:1996;993-998.
68. Mailander V., Heine R., Deymeer F., Lehmann Horn F. Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet. 58:1996;317-324.
69. Meyer Kleine C., Steinmeyer K., Ricker K., et al. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet. 57:1995;1325-1334.
70. Heine R., George A.L. Jr, Pika U., et al. Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet. 3:1994;1123-1128.
71. George A.L. Jr, Sloan Brown K., Fenichel G.M., et al. Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet. 3:1994;2071-2072.
72. Lorenz C., Meyer Kleine C., Steinmeyer K., et al. Genomic organization of the human muscle chloride channel CIC-1 and analysis of novel mutations leading to Becker-type myotonia. Hum Mol Genet. 3:1994;941-946.
73. Meyer Kleine C., Ricker K., Otto M., Koch M.C. A recurrent 14 bp deletion in the CLCN1 gene associated with generalized myotonia (Becker). Hum Mol Genet. 3:1994;1015-1016.
74. George A.L. Jr, Crackower M.A., Abdalla J.A., et al. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet. 3:1993;305-310.
75. Steinmeyer K., Lorenz C., Pusch M., et al. Multimeric structure of CIC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen). Embo J. 13:1994;737-743.
76. Lehmann Horn F., Mailander V., Heine R., George A.L. Myotonia levior is a chloride channel disorder. Hum Mol Genet. 4:1995;1397-1402.
77. Griggs R.C., Bender A.N., Tawil R. A puzzling case of periodic paralysis. Muscle Nerve. 19:1996;362-364.
78. Riggs J.E., Griggs R.C. Diagnosis and treatment of the periodic paralyses. Neuropharmacology. 4:1979;123-128.
79. Riggs J.E., Griggs R.C., Moxley R.T.D. Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. A possible relationship to acetazolamide's beneficial effect in hypokalemic periodic paralysis. Arch Neurol. 41:1984;35-38.